Prevention and management of erectile dysfunction following radical prostatectomy

Urologic Clinics of North America

Volumn 28, Issue 3, 2001, Pages 613-627

  McCullough, Andrew R ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PAPAVERINE; PHENTOLAMINE; PROSTAGLANDIN E1; SILDENAFIL;

EJACULATION; ERECTILE DYSFUNCTION; HUMAN; IMPOTENCE; MALE; NONHUMAN; PAIN; PENIS ERECTION; PENIS PROSTHESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATECTOMY; REVIEW; VACUUM ERECTION DEVICE;

EID: 0034807706     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70166-X     Document Type: Article

References (67)

1. EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction
2. Why do so many people drop out from autoinjection therapy for impotence?
3. Papaverine testing of impotent patients following nerve-sparing radical prostatectomy
4. The effect of adeno-associated virus-mediated brain derived neurotrophic factor in an animal model for neurogenic impotence
5. The role of radical prostatectomy in the treatment of prostate cancer
6. Detailed anatomy of penile neurovascular structures: Surgical significance
7. The hemodynamics of vacuum constriction erections: Assessment by color Doppler ultrasound
8. Is cavernous injection of papaverine a reliable screening devise?
9. Inflatable penile prostheses
10. Long-term results with vacuum constriction device
11. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy
12. Damage to the erectile function following radical pelvic surgery: Prevalence of veno-occlusive dysfunction
13. Pharamcological treatment of erectile dysfunction after radical prostatectomy
14. Complications of intracavernosal therapy for impotence
15. Impotence and its medical and psychological correlates: Results of the Massachusetts male aging study
16. Changes in penile morphometrics in men with erectile dysfunction after nerve-sparing radical prostatectomy
17. Predictive value of nocturnal penile tumescence (NPT) on the long term return of erectile function in men with erectile dysfunction (ED) after nerve sparing radical prostatectomy (NSRRP)
18. Nocturnal penile tumescence activity in 81 patients presenting with erectile dysfunction after nerve sparing radical prostatectomy
19. Nerve sparing radical prostatectomy: A different view
20. Oral sildenafil in the treatment of erectile dysfunction: Sildenafil Study Group
21. Perineal versus retropubic radical prostatectomy for T1, T2 prostate cancer
22. The anatomic radical perineal prostatectomy: A contemporary and anatomic approach
23. Health-related quality of life in Australian men remaining disease-free after radical prostatectomy
24. Time dependent patient satisfaction with sildenafil for erectile dysfunction (ED) after nerve sparing radical retropubic prostatectomy
25. Interposition of sural nerves restores function of cavernous nerves resected during radical prostatectomy
26. Use of the Cavermap to predict potency following radical prostatecomy
27. Apoptosis in the rat penis after penile denervation
28. Early experience with intraoperative cavernous nerve stimulation with penile tumescence monitoring to improve nerve sparing during radical prostatectomy
29. Orgasm after radical prostatectomy
30. Erectile dysfunction after radical prostatectomy: Value of preoperative programming of intracavernous injections
31. The effect of vascular endothelial growth factor on a rat model of arterial impotence
32. Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa: A detailed anatomical study of the adult male pelvis
33. Detailed evaluation of sexual function after radical prostatectomy: Is patient satisfaction correlated with the quality of erections?
34. Treatment of erectile dysfunction with sildenafil
35. Comparison of penile color duplex Doppler (PCDD) results in sildenafil responders and non-responders in men with erectile dysfunction (ED) after nerve sparing radical prostatectomy (NSRRP)
36. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil
37. Sildenafil taken at bedtime significantly increases nocturnal erectile activity. Results of a prospective Rigiscan study
38. The early postoperative concerns of men after radical prostatectomy
39. Immediate sexual rehabilitation by simultaneous placement of penile prosthesis with radical prostatectomy: Results in 100 patients
40. The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy
41. Cancer and the family: Strategies to assist spouses
42. A brief male sexual function inventory for urology
43. Radical retropubic prostatectomy: The influence of accessory pudendal arteries on the recovery of sexual function
44. Sexual function following radical prostatectomy: Influence of preservation of neurovascular bundles
45. Cavernous nerve grafts restore erectile function in denervated rats
46. Intraoperative electrical stimulation of cavernosal nerves with monitoring of intracorporeal pressure in patients undergoing nerve sparing radical prostatectomy
47. An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery
48. Erectile dysfunction after radical prostatectomy: Etiopathology and treatment
49. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction
50. Radical prostatectomy in patients with indwelling inflatable penile prosthesis
51. Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function
52. Intracavernosal drug-induced erection therapy versus external vacuum devices in the treatment of erectile dysfunction
53. Criteria for examiner-independent nocturnal penile tumescence and rigidity monitoring (NPTR): Correlations to invasive diagnostic methods
54. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study
55. Patient reported impotence and incontinence after nerve sparing radical prostatectomy
56. Treatment outcome after radical prostatectomy is not adversely affected by a pre-existing penile prosthesis
57. Quality of life after radical prostatectomy
58. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy
59. Use of intraoperative video documentation to improve sexual function after radical retropubic prostatectomy
60. Anatomic radical prostatectomy: Evolution of the surgical technique
61. Radical prostatectomy, preservation of sexual function, cancer control: The controversy
62. Neoplasms of the urogenital tract
63. Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer
64. Role of Viagra after radical prostatectomy
65. Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra)